Assessing omega-3 fatty acid supplementation during pregnancy and lactation to optimize maternal mental health and childhood cognitive development

Clinical Lipidology

Volumn 7, Issue 1, 2012, Pages 93-109

  Klemens, Chelsea M ^a   Salari, Kataneh ^b   Mozurkewich, Ellen L ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

child development; mental health; omega 3 fatty acid; placenta

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ALPHA TOCOPHEROL; ARACHIDONIC ACID; COD LIVER OIL; CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO;

ARTIFICIAL MILK; BIOLOGICAL ACTIVITY; BRAIN DEVELOPMENT; CHILD DEVELOPMENT; COGNITIVE DEVELOPMENT; DEPRESSION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG NOMENCLATURE; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; HUMAN; INTERVENTION STUDY; LACTATION; LOW DRUG DOSE; MATERNAL NUTRITION; MATERNAL WELFARE; MENTAL HEALTH; NEUROPROTECTION; NONHUMAN; OBSERVATIONAL STUDY; PERINATAL DEPRESSION; PLACENTAL TRANSFER; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY ANALYSIS;

EID: 84856813203     PISSN: 17460875     EISSN: 17584302     Source Type: Journal    
DOI: 10.2217/clp.12.1     Document Type: Review

References (91)

1. Gomez Candela C, Bermejo Lopez LM, Loria Kohen V. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr. Hosp. 26(2), 323-329 (2011).
2. Adams P, Lawson S, Sanigorski A, Sinclair A. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31, S157-S161 (1996).
3. Haggarty P. Fatty acid supply to the human fetus. Annu. Rev. Nutr. 30, 237-255 (2010).
4. Otto S, de Groot R, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot. Essent. Fatty Acids 69, 237-243 (2003). (Pubitemid 37463804)
5. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Stoll AL. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 67(12), 1954-1967 (2006). (Pubitemid 46048194)
6. Dziechciarz P, Horvath A, Szajewska H. Effects of n-3 long-chain polyunsaturated fatty acid supplementation during pregnancy and/or lactation on neurodevelopment and visual function in children: a systematic review of randomized controlled trials. J. Am. Coll. Nutr. 29(5), 443-454 (2010).
7. Davis-Bruno K, Tassinari MS. Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature. Birth Defects Res. B Dev. Reprod. Toxicol. 92(3), 240-250 (2011).
8. Kremmyda LS, Vlachava M, Noakes PS, Diaper ND, Miles EA, Calder PC. Atopy risk in infants and children in relation to early exposure to fsh, oily fsh, or long-chain omega-3 fatty acids: a systematic review. Clin. Rev. Allergy Immunol. 41(1), 36-66 (2011).
9. Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A. Signifcance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur. J. Pediatr. 169, 149-164 (2010).
10. Koletzko B, Lien E, Agostoni C et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J. Perinat. Med. 36(1), 5-14 (2008).
11. Lumia M, Luukkainen P, Tapanainen H et al. Dietary fatty acid composition during pregnancy and the risk of asthma in the offspring. Pediatr. Allergy Immunol. 22(8), 827-835 (2011).
12. Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58(20), 2047-2067 (2011).
13. Shaikh SR, Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am. J. Clin. Nutr. 84(6), 1277-1289 (2006). (Pubitemid 44912808)
14. Hibbeln JR, Davis JM, Steer C et al. Maternal seafood consumption in pregnancy and neuro developmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369(9561), 578-585 (2007). (Pubitemid 46241443)
15. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fatty Acids 75(4-5), 329-349 (2006). (Pubitemid 44442917)
16. Zhang C, Bazan NG. Lipid-mediated cell signaling protects against injury and neurodegeneration. J. Nutr. 140(4), 858-863 (2010).
17. Ramakrishnan U. Fatty acid status and maternal mental health. Matern. Child Nutr. 7(Suppl. 2), 99-111 (2011).
18. Grintal B, Champeil-Potokar G, Lavialle M, Vancassel S, Breton S, Denis I. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid. Neurochem. Int. 54(8), 535 (2009).
19. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot. Essent. Fatty Acids 75(4-5), 259-269 (2006). (Pubitemid 44442912)
20. Levant B, Ozias M, Carlson S. Specifc brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-defcient diet. J. Nutr. 137(1), 130-134 (2007). (Pubitemid 46052870)
21. Levant B, Ozias M, Davis P et al. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats. Psychoneuroendocrinology 33(9), 1279-1292 (2008).
22. Davis PF, Ozias MK, Carlson SE et al. Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status. Nutr. Neurosci. 13(4), 161-169 (2010).
23. Kim H. Novel metabolism of docosahexaenoic acid in neural cells. J. Biol. Chem. 282(26), 18661-18665 (2007). (Pubitemid 47100128)
24. Bazan NG. Omega-3 fatty acids, proinfammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care 10(2), 136-141 (2007). (Pubitemid 46220304)
25. Farooqui AA, Horrocks LA, Farooqui T. Modulation of infammation in brain: a matter of fat. J. Neurochem. 101(3), 577-599 (2007). (Pubitemid 46633316)
26. Farooqui AA. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders. Neuroscientist 15(4), 392-407 (2009).
27. Lotrich FE, El-Gabalawy H, Guenther LC, Ware CF. The role of infammation in the pathophysiology of depression: different treatments and their effects. J. Rheumatol. Suppl. 88, 48-54 (2011).
28. Schiepers O, Wichers M, Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 201-217 (2005). (Pubitemid 40202906)
29. Maes M, Yirmyia R, Noraberg J et al. The infammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 24(1), 27-53 (2009).
30. Corwin EJ, Johnston N, Pugh L. Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the frst month postpartum. Biol. Res. Nurs. 10(2), 128-133 (2008).
31. Corwin EJ, Pajer K. The psychoneuroimmunology of postpartum depression. J. Womens Health 17(9), 1529-1534 (2008).
32. Maes M, Lin A, Ombelet W et al. Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms. Psychoneuroendocrinology 25, 121-137 (2000). (Pubitemid 29525386)
33. Ferrucci L, Cherubini A, Bandinelli S et al. Relationship of plasma polyunsaturated fatty acids to circulating infammatory markers. J. Clin. Endocrinol. Metab. 91(2), 439-446 (2006). (Pubitemid 43236907)
34. Kawashima A, Harada T, Kami H, Yano T, Imada K, Mizuguchi K. Effects of eicosapentaenoic acid on synaptic plasticity fatty acid profle and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells. J. Nutr. Biochem. 21(4), 268-277 (2010).
35. Moore SA, Yoder E, Murphy S, Dutton GR, Spector AA. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J. Neurochem. 56(2), 518-524 (1991). (Pubitemid 21901992)
36. Bhattacharya A, Sun D, Rahman M, Fernandes G. Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fsh oils differentially alter pro-infammatory cytokines in peritoneal macrophages from C57BL/6 female mice. J. Nutr. Biochem. 18(1), 23-30 (2007). (Pubitemid 44827716)
37. Weldon SM, Mullen AC, Loscher CE, Hurley LA, Roche HM. Docosahexaenoic acid induces an anti-infammatory profle in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J. Nutr. Biochem. 18(4), 250-258 (2007). (Pubitemid 46389578)
38. Serhan CN, Petasis NA. Resolvins and protectins in infammation resolution. Chem. Rev. 111(10), 5922-5943 (2011).
39. Xu Z, Zhang L, Liu T et al. Resolvins RvE1 and RvD1 attenuate infammatory pain via central and peripheral actions. Nat. Med. 16(5), 592-597 (2010).
40. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T Perinatal depression: a systematic review of prevalence and incidence. Obstet. Gynecol. 106(5 Pt 1), 1071-1083 (2005). (Pubitemid 41532916)
41. Hibbeln J. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 69, 15-29 (2002). (Pubitemid 34722867)
42. Golding J, Steer C, Emmett P, Davis JM, Hibbeln JR. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fsh. Epidemiology 20(4), 598-603 (2009).
43. Jans LA, Giltay EJ, Van der Does AJ. The effcacy of n-3 fatty acids DHA and EPA (fsh oil) for perinatal depression. Br. J. Nutr. 104(11), 1577-1585 (2010).
44. Makrides M, Gibson RA, McPhee AJ et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 304(15), 1675-1683 (2010).
45. Llorente A, Jensen C, Voigt R, Fraley J, Berretta M, Heird W. Effect of maternal docasahexaenoic acid supplementation on postpartum depression and information processing. Am. J. Obstet. Gynecol. 188, 1348-1353 (2003). (Pubitemid 36589134)
46. Krauss-Etschmann S, Shadid R, Campoy C et al. Effects of fsh-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am. J. Clin. Nutr. 85(5), 1392-1400 (2007). (Pubitemid 46740484)
47. Rees AM, Austin MP, Parker GB. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust. NZ J. Psychiatry 42(3), 199-205 (2008). (Pubitemid 351234189)
48. Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J. Affect. Disord. 110(1-2), 142-148 (2008).
49. Su KP, Huang SY, Chiu TH et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry 69(4), 644-651 (2008).
50. Mattes E, McCarthy S, Gong G et al. Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain Behav. Immun. 23(3), 380-388 (2009).
51. Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, Muskiet FA. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog. Neuropsychopharmacol. Biol. Psychiatry 33(1), 49-52 (2009).
52. Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis. 6, 21 (2007).
53. Martins JG. EPA but not DHA appears to be responsible for the effcacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J. Am. Coll. Nutr. 28(5), 525-542 (2009).
54. Mozurkewich E, Chilimigras J, Klemens C et al. The mothers, omega-3 and mental health study. BMC Pregnancy Childbirth 11, 46 (2011).
55. Purvis JM, Clandinin MT, Hacker RR. Fatty acid accretion during perinatal brain growth in the pig. A model for fatty acid accretion in human brain. Comp. Biochem. Physiol. B 72(2), 195-199 (1982).
56. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 4(2), 121-129 (1980). (Pubitemid 10064580)
57. Coti Bertrand P, O'Kusky JR, Innis SM. Maternal dietary (n-3) fatty acid defciency alters neurogenesis in the embryonic rat brain. J. Nutr. 136(6), 1570-1575 (2006). (Pubitemid 43765364)
58. Jorgensen MH, Nielsen PK, Michaelsen KF, Lund P, Lauritzen L. The composition of polyunsaturated fatty acids in erythrocytes of lactating mothers and their infants. Matern. Child Nutr. 2(1), 29-39 (2006). (Pubitemid 43741012)
59. Cao D, Kevala K, Kim J et al. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J. Neurochem. 111(2), 510-521 (2009).
60. Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139(3), 991-997 (2006).
61. Sinha RA, Khare P, Rai A et al. Anti-apoptotic role of omega-3-fatty acids in developing brain: perinatal hypothyroid rat cerebellum as apoptotic model. Int. J. Dev. Neurosci. 27(4), 377-383 (2009).
62. Kuperstein F, Eilam R, Yavin E. Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary defciency J. Neurochem. 106(2), 662-671 (2008).
63. Salem JN. Mechanism of action of docosahexaenoic acid in the nervous system. Lipids 36(9), 945-959 (2001).
64. Yavin E. Versatile roles of docosahexaenoic acid in the prenatal brain: from pro-and anti-oxidant features to regulation of gene expression. Prostaglandins Leukot. Essent. Fatty Acids 75(3), 203-211 (2006). (Pubitemid 44292525)
65. Berman DR, Mozurkewich E, Liu Y, Barks J. Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am. J. Obstet. Gynecol. 200(3), 305.E1-305.E6 (2009).
66. Berman D, Liu Y, Barks J, Mozurkewich E. Treatment with docosahexaenoic acid after hypoxia-ischemia improves forepaw placing in a rat model of perinatal hypoxia-ischemia. Am. J. Obstet. Gynecol. 203(4), 385.E1-385.E5 (2010).
67. Berman D, Liu Y, Barks J, Mozurkewich E. Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic infammation. Am. J. Obstet. Gynecol. 202(5), 469 E1-E6 (2010).
68. Lauritzen L, Carlson SE. Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status. Matern. Child Nutr. 7(Suppl. 2), 41-58 (2011).
69. Koletzko B, Larque E, Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J. Perinat. Med. 35(Suppl. 1), S5-S11 (2007). (Pubitemid 46279663)
70. Larque E, Krauss-Etschmann S, Campoy C et al. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am. J. Clin. Nutr. 84(4), 853-861 (2006). (Pubitemid 44715668)
71. Hanebutt FL, Demmelmair H, Schiessl B, Larqué E, Koletzko B. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin. Nutr. 27(5), 685-693 (2008).
72. Kuipers RS, Luxwolda MF, Janneke Dijck-Brouwer DA, Muskiet FAJ. Intrauterine, postpartum and adult relationships between arachidonic acid (AA) and docosahexaenoic acid (DHA). Prostaglandins Leukot. Essent. Fatty Acids 85(5), 245-252 (2011).
73. Boucher O, Burden MJ, Muckle G et al. Neurophysiologic and neurobehavioral evidence of benefcial effects of prenatal omega-3 fatty acid intake on memory function at school age. Am. J. Clin. Nutr. 93(5), 1025-1037 (2011).
74. Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment of children at age 2(1/2) years after maternal fsh oil supplementation in pregnancy: a randomised controlled trial. Arch. Dis. Child Fetal Neonatal Ed. 93(1), F45-F50 (2008).
75. Helland IG, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111, 39-44 (2003).
76. Helland IB, Smith L, Blomen B, Saarem K, Saugstad OD, Drevon CA. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 122(2), E472-E479 (2008).
77. Delgado-Noguera MF, Calvache JA, Bonfll Cosp X. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development. Cochrane Database Syst. Rev. 12, CD007901 (2010).
78. Judge MP, Harel O, Lammi-Keefe CJ. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: beneft for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am. J. Clin. Nutr. 85(6), 1572-1577 (2007). (Pubitemid 46890426)
79. Tofail F, Kabir I, Hamadani JD et al. Supplementation of fsh-oil and soy-oil during pregnancy and psychomotor development of infants. J. Health Popul. Nutr. 24(1), 48-56 (2006). (Pubitemid 43984539)
80. Jensen CL, Voigt RG, Prager TC et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am. J. Clin. Nutr. 82(1), 125-132 (2005). (Pubitemid 41721867)
81. Lauritzen L, Jorgensen MH, Olsen SF, Straarup EM, Michaelsen KF. Maternal fsh oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod. Nutr. Dev. 45(5), 535-547 (2005). (Pubitemid 41511880)
82. Cheatham CL, Nerhammer AS, Asserhoj M, Michaelsen KF, Lauritzen L. Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids 46(7), 637-645 (2011).
83. Helland IB, Saugstad OD, Smith L et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108(5), E82 (2001).
84. Escolano-Margarit MV, Ramos R, Beyer J et al. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. J. Nutr. 141(6), 1216-1223 (2011).
85. Campoy C, Escolano-Margarit MV, Ramos R et al. Effects of prenatal fsh-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6.5 year of age. Am. J. Clin. Nutr. 94(Suppl.), 1880S-1888S (2011).
86. van Goor SA, Janneke Dijck-Brouwer DA, Erwich JJHM, Schaafsma A, Hadders-Algra M. The infuence of supplemental docosahexaenoic and arachidonic acids during pregnancy and lactation on neurodevelopment at eighteen months. Prostaglandins Leukot. Essent. Fatty Acids 84(5-6), 139-146 (2011).
87. Makrides M, Gibson RA, McPhee AJ et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 301(2), 175-182 (2009).
88. Schulzke S, Patole S, Simmer K. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst. Rev. 2, CD000375 (2011).
89. Agostoni C, Zuccotti GV, Radaelli G et al. Docosahexaenoic acid supplementation and time at achievement of gross motor milestones in healthy infants: a randomized, prospective, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 89(1), 64-70 (2009).
90. Simmer K, Patole SK, Rao SC. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. 12, CD000376 (2011).
91. Drover JR, Hoffman DR, Castaneda YS et al. Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Hum. Dev. 87(3), 223-230 (2011).